Clinical Drug Experience Knowledgebase

berberine (1 trial)

cisatracurium (nimbex) (1 trial)

deng zhan sheng mai (1 trial)

eltrombopag (promacta) (1 trial)

ethambutol (myambutol) (1 trial)

evolocumab (repatha) (1 trial)

glucose (1 trial)

interferon alpha-2b (Intron-A) (2 trials)

isoniazid (nydrazid) (1 trial)

lamivudine (epivir) (1 trial)

levofloxacin (levaquin) (1 trial)

lopinavir (Kaletra) (1 trial)

nafamostat (ronastat) (1 trial)

nevirapine (viramune) (1 trial)

prednisone (meticorten) (2 trials)

pyrazinamide (Aldinamide) (1 trial)

rifampin (1 trial)

ritonavir (Norvir) (1 trial)

rocuronium (zemuron) (1 trial)

thrombopoietin (1 trial)

urea (1 trial)

vecuronium (norcuron) (1 trial)

zidovudine (retrovir) (1 trial)

131i-lipiodol (Lipiodol) (1 trial)

alpha-lipoic acid (1 trial)

anlotinib (1 trial)

carboplatin (paraplatin) (1 trial)

cinobufacin (1 trial)

cisplatin (platinol) (3 trials)

cyclophosphamide (cytoxan) (1 trial)

cyclosporine (sandimmune) (1 trial)

dexamethasone (1 trial)

docetaxel (taxotere) (2 trials)

endostatin (endostar) (3 trials)

epirubicin (ellence) (2 trials)

erlotinib (tarceva) (1 trial)

gelatin (1 trial)

gemcitabine (gemzar) (3 trials)

gimeracil (1 trial)

lenvatinib (lenvima) (1 trial)

levamisole (ergamisol) (1 trial)

nedaplatin (1 trial)

oteracil (1 trial)

oxaliplatin (eloxatin) (2 trials)

pemetrexed (alimta) (1 trial)

pomalidomide (pomalyst) (1 trial)

rituximab (rituxan) (2 trials)

sodium chloride (1 trial)

tislelizumab (1 trial)

tranexamic acid (cyklokapron) (1 trial)

vincristine (oncovin) (1 trial)

capecitabine (xeloda) (1 trial)

etoposide (vepesid) (1 trial)

hs-20089 (1 trial)

Telitacicept (1 trial)

vinorelbine (navelbine) (1 trial)

autologous natural killer cells (1 trial)

eplerenone (inspra) (1 trial)

albuterol (proventil) (1 trial)

gabapentin (neurontin) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

pregabalin (lyrica) (1 trial)

remifentanil (ultiva) (1 trial)

sodium bicarbonate (1 trial)